Federal regulators are warning about safety concerns amid the rising popularity of drugs like Ozempic and Wegovy for weight loss. The FDA is warning consumers that off-brand forms of the medications could be unsafe.
Ozempic is approved by the FDA to treat Type 2 diabetes, but some doctors prescribe the medication "off-label" for weight loss, as is permissible by the FDA.
Ozempic and Wegovy are not currently covered for weight loss under most Medicare and Medicaid programs.Mario Tama/Getty Images
México Últimas Noticias, México Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
FDA warns consumers not to use off-brand versions of Ozempic, WegovyConsumers should only use semaglutide prescribed by a health care provider and filled by a licensed pharmacy, FDA said.
Leer más »
FDA warns consumers not to use off-brand versions of Ozempic, WegovySales of semaglutide products have soared in the past few years after the drug was shown to spur fast and significant weight loss.
Leer más »
FDA warns consumers not to use off-brand versions of Ozempic, WegovyThe U.S. Food and Drug Administration is warning consumers not to use versions of the popular weight-loss drug used in Ozempic and Wegovy and sold online because they might not contain the same ingredients as prescription products and may not be safe or effective.
Leer más »
FDA warns consumers not to use off-brand versions of Ozempic, WegovyThe U.S. Food and Drug Administration is warning consumers not to use versions of the popular weight-loss drug used in Ozempic and Wegovy and sold online because they might not contain the same ingredients as prescription products and may not be safe or effective. Agency officials said this week that they have received reports of problems after patients used versions of semaglutide, the active ingredient in the brand-name medications, which have been compounded or mixed in pharmacies. Consumers should only use semaglutide prescribed by a health are provider and filled by a licensed pharmacy, FDA said.
Leer más »
FDA warns consumers not to use off-brand versions of Ozempic, WegovyThe U.S. Food and Drug Administration is warning consumers not to use off-brand versions of the popular weight-loss drugs Ozempic and Wegovy because they might not contain the same ingredients as the prescription products and may not be safe or effective.
Leer más »
Ozempic, Wegovy and pregnancy risk: What you need to know about the issueStudies show that animals given semaglutide experience higher rates of miscarriage, birth defects and small fetal size — prompting FDA calls for investigations into Ozempic and Wegovy. Novo Nordisk weighs in.
Leer más »